BioPharma Credit (BPCR) Stock Chart & Stock Price History GBX 0.84 0.00 (-0.48%) As of 05:41 AM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendInsider TradesBuy This Stock BioPharma Credit Stock Price Performance 5 Day Performance+0.24%1 Month Performance-5.86%3 Month Performance-2.34%6 Month Performance-3.69%Year-To-Date Performance-5.43%1 Year Performance-4.57% Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCR Stock Chart for Wednesday, April, 16, 2025 BPCR Chart by TradingViewRemove Ads BioPharma Credit Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/15/2025GBX 0.83GBX 0.84+1.20%GBX 0.85GBX 0.83342,435 shs£997.26 million04/14/2025GBX 0.83GBX 0.83-0.48%GBX 0.84GBX 0.83742,991 shs£985.39 million04/11/2025GBX 0.83GBX 0.83+0.24%GBX 0.84GBX 0.82590,959 shs£990.14 million04/10/2025GBX 0.80GBX 0.83+3.48%GBX 0.84GBX 0.82981,064 shs£987.76 million04/09/2025GBX 0.84GBX 0.80-4.29%GBX 0.86GBX 0.801.72 million shs£954.52 million04/09/2025GBX 0.84GBX 0.80-4.29%GBX 0.86GBX 0.801.72 million shs£954.52 million04/08/2025GBX 0.85GBX 0.84-0.94%GBX 0.86GBX 0.84738,680 shs£997.26 million04/08/2025GBX 0.85GBX 0.84-0.94%GBX 0.86GBX 0.84738,680 shs£997.26 million04/07/2025GBX 0.86GBX 0.85-1.62%GBX 0.87GBX 0.841.44 million shs£1.01 billion04/04/2025GBX 0.87GBX 0.86-1.15%GBX 0.87GBX 0.86319,248 shs£1.02 billion Get the Latest News and Ratings for BPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. 04/03/2025GBX 0.89GBX 0.87-1.58%GBX 0.88GBX 0.87306,854 shs£1.04 billion04/02/2025GBX 0.89GBX 0.89-0.23%GBX 0.89GBX 0.88277,952 shs£1.05 billion04/01/2025GBX 0.89GBX 0.89+0.23%GBX 0.89GBX 0.881.36 million shs£1.05 billion03/31/2025GBX 0.89GBX 0.89-0.23%GBX 0.90GBX 0.891.83 million shs£1.05 billion03/28/2025GBX 0.88GBX 0.89+0.79%GBX 0.89GBX 0.88618,360 shs£1.05 billion03/27/2025GBX 0.89GBX 0.88-0.56%GBX 0.88GBX 0.872.73 million shs£1.05 billion03/26/2025GBX 0.88GBX 0.89+0.91%GBX 0.89GBX 0.87551,605 shs£1.05 billion03/25/2025GBX 0.88GBX 0.88-0.45%GBX 0.89GBX 0.871.67 million shs£1.04 billion03/24/2025GBX 0.89GBX 0.88-0.68%GBX 0.89GBX 0.88655,470 shs£1.05 billion03/21/2025GBX 0.88GBX 0.89+0.45%GBX 0.89GBX 0.88333,264 shs£1.05 billion03/20/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88742,598 shs£1.05 billion03/19/2025GBX 0.89GBX 0.88-0.45%GBX 0.89GBX 0.881.34 million shs£1.05 billion03/18/2025GBX 0.89GBX 0.89-0.22%GBX 0.89GBX 0.88540,835 shs£1.05 billion03/17/2025GBX 0.89GBX 0.89+0.23%GBX 0.89GBX 0.88343,118 shs£1.06 billion Related Companies Alliance Trust Stock Price Chart Polar Capital Technology Trust Stock Price Chart Petershill Partners Stock Price Chart 3i Infrastructure Stock Price Chart Burford Capital Stock Price Chart JPMorgan Global Growth & Income Stock Price Chart RIT Capital Partners Stock Price Chart Man Group Stock Price Chart abrdn Stock Price Chart HgCapital Trust Stock Price Chart Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BPCR) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersThe Crypto Market is About to Change LivesI've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredRadical shift coming to the stock market (read this ASAP)This is an urgent warning for all American investors … In a matter of days, we could see a radical shift in...Weiss Ratings | SponsoredFirst look: The $3,500 iPhoneDid you hear that just before Trump's tariffs took effect, Apple sent five cargo planes packed with MacBooks a...Stansberry Research | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
